Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis.
Saved in:
| Title: | Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis. |
|---|---|
| Authors: | Dunn K; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Rogers R; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Simonson RB; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Luo D; Janssen Research & Development, LLC, Titusville, NJ, USA., Sheng S; Janssen Research & Development, LLC, Titusville, NJ, USA., Kassam PT; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Seyedkazemi S; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Hardy H; Janssen Research & Development, LLC, Titusville, NJ, USA. |
| Source: | HIV research & clinical practice [HIV Res Clin Pract] 2021 Apr; Vol. 22 (2), pp. 55-61. Date of Electronic Publication: 2021 May 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Group Country of Publication: England NLM ID: 101738312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-7470 (Electronic) Linking ISSN: 25787470 NLM ISO Abbreviation: HIV Res Clin Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
